Antiretroviral therapy coverage for PMTCT in Netherlands
Netherlands: Antiretroviral therapy coverage for PMTCT was 55.0% in 2009. ▲ Rising
Antiretroviral therapy coverage for PMTCT in Netherlands, 2000–2009
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Netherlands recorded 55.0% for antiretroviral therapy coverage for pmtct in 2009. That is the highest value across all 10 years on record.
That represents a change of up 10.0% on the previous year and up 266.7% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Netherlands peaked at 55.0% in 2009 and was at its lowest, 15.0%, in 2000.
That places Netherlands 64th out of 84 countries with data for 2009, putting it in the bottom quarter.
Antiretroviral therapy coverage for PMTCT in Netherlands, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 15.0% | — |
| 2001 | 20.0% | +33.3% |
| 2002 | 25.0% | +25.0% |
| 2003 | 30.0% | +20.0% |
| 2004 | 35.0% | +16.7% |
| 2005 | 40.0% | +14.3% |
| 2006 | 45.0% | +12.5% |
| 2007 | 50.0% | +11.1% |
| 2008 | 50.0% | +0.0% |
| 2009 | 55.0% | +10.0% |
Netherlands compared with similar countries
- Netherlands's 55.0% is below the median for high income countries, which is 89.0%, 62% of the median. (8 countries reporting)
- Netherlands's 55.0% is below the median for Europe & Central Asia, which is 91.0%, 60% of the median. (8 countries reporting)
Countries ranked near Netherlands
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.4989 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0239 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5005 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Netherlands?
- Antiretroviral therapy coverage for pmtct in Netherlands was 55.0% in 2009, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Netherlands?
- The highest recorded value was 55.0% in 2009.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Netherlands?
- The lowest recorded value was 15.0% in 2000.
- How does Netherlands rank for antiretroviral therapy coverage for pmtct?
- Netherlands ranks 64th out of 84 countries with data for 2009.
- Is antiretroviral therapy coverage for pmtct rising or falling in Netherlands?
- Over the last ten years it is up 266.7%. The long-run trend across the full record is rising.
- Where does this Netherlands data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).